Rationale and radiopharmaceuticals for myocardial imaging

Area of Science:

• Nuclear medicine
• Cardiovascular imaging
• Radiopharmaceutical science

Background:

• Static radionuclide imaging is crucial for evaluating regional myocardial perfusion and detecting acute myocardial infarction.
• Thallium-201 is a key radiopharmaceutical for assessing regional blood flow, with decreased uptake indicating ischemic lesions.
• Current limitations of Thallium-201 include high cost, limited supply, and suboptimal imaging characteristics.

Purpose of the Study:

• To evaluate the utility of radionuclide imaging in diagnosing myocardial perfusion and infarction.
• To compare the effectiveness of Thallium-201 for perfusion imaging and Technetium-99m chelates for infarct imaging.
• To determine the justification for a dual tracer approach in patients with suspected coronary artery disease and/or myocardial infarction.

Main Methods:

• Utilized static radionuclide imaging techniques.
• Investigated Thallium-201 as a myocardial perfusion indicator.
• Examined various Technetium-99m chelates, particularly pyrophosphate, for infarct imaging.

Main Results:

• Ischemic lesions were identified as areas of reduced Thallium-201 uptake.
• Positive infarct imaging was achievable with Technetium-99m chelates, with pyrophosphate showing promise.
• Quantitative infarct size measurements were deemed not justifiable due to an unclear uptake mechanism.

Conclusions:

• Perfusion imaging and infarct imaging provide complementary diagnostic data.
• A dual tracer approach, combining Thallium-201 and Technetium-99m, is justifiable for evaluating patients with suspected coronary artery disease and/or myocardial infarction.